Market Closed -
Bombay S.E.
11:01:25 04/06/2024 BST
|
5-day change
|
1st Jan Change
|
47.3
INR
|
-4.96%
|
|
-4.66%
|
-26.16%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
187.2
|
217.9
|
38.77
|
302.5
|
403.3
|
635.6
|
Enterprise Value (EV)
1 |
196.6
|
230.5
|
50
|
255.4
|
447.4
|
630
|
P/E ratio
|
77.8
x
|
-49
x
|
-2.03
x
|
49.3
x
|
53.9
x
|
83.1
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
7.7
x
|
5.08
x
|
0.37
x
|
2.52
x
|
1.59
x
|
3.47
x
|
EV / Revenue
|
8.09
x
|
5.38
x
|
0.48
x
|
2.13
x
|
1.76
x
|
3.44
x
|
EV / EBITDA
|
51.7
x
|
-34.4
x
|
-1.11
x
|
44.5
x
|
34
x
|
66
x
|
EV / FCF
|
-
|
119,352,275
x
|
2,145,327
x
|
-4,013,820
x
|
-5,429,070
x
|
156,014,186
x
|
FCF Yield
|
-
|
0%
|
0%
|
-0%
|
-0%
|
0%
|
Price to Book
|
3.37
x
|
4.43
x
|
1.32
x
|
2.42
x
|
1.41
x
|
2.16
x
|
Nbr of stocks (in thousands)
|
3,820
|
3,820
|
3,820
|
3,820
|
8,316
|
8,316
|
Reference price
2 |
49.00
|
57.05
|
10.15
|
79.20
|
48.50
|
76.43
|
Announcement Date
|
12/08/18
|
05/09/19
|
08/09/20
|
02/06/22
|
02/06/22
|
30/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
24.3
|
42.86
|
104.1
|
119.9
|
254.1
|
183.2
|
EBITDA
1 |
3.801
|
-6.708
|
-45.13
|
5.737
|
13.16
|
9.545
|
EBIT
1 |
3.59
|
-8.419
|
-47.06
|
5.121
|
7.533
|
3.217
|
Operating Margin
|
14.77%
|
-19.64%
|
-45.2%
|
4.27%
|
2.96%
|
1.76%
|
Earnings before Tax (EBT)
1 |
2.458
|
-9.978
|
-49.34
|
8.327
|
9.42
|
10.26
|
Net income
1 |
1.963
|
-4.445
|
-19.06
|
6.143
|
7.057
|
7.688
|
Net margin
|
8.08%
|
-10.37%
|
-18.31%
|
5.12%
|
2.78%
|
4.2%
|
EPS
2 |
0.6300
|
-1.164
|
-4.990
|
1.608
|
0.9000
|
0.9200
|
Free Cash Flow
|
-
|
1.931
|
23.31
|
-63.62
|
-82.42
|
4.038
|
FCF margin
|
-
|
4.5%
|
22.39%
|
-53.06%
|
-32.43%
|
2.2%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
42.31%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
52.53%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/08/18
|
05/09/19
|
08/09/20
|
02/06/22
|
02/06/22
|
30/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
9.43
|
12.5
|
11.2
|
-
|
44.1
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
47.2
|
-
|
5.59
|
Leverage (Debt/EBITDA)
|
2.482
x
|
-1.867
x
|
-0.2487
x
|
-
|
3.352
x
|
-
|
Free Cash Flow
|
-
|
1.93
|
23.3
|
-63.6
|
-82.4
|
4.04
|
ROE (net income / shareholders' equity)
|
4.47%
|
-14.8%
|
-122%
|
9.01%
|
3.43%
|
2.65%
|
ROA (Net income/ Total Assets)
|
3.06%
|
-5.19%
|
-27.5%
|
2.23%
|
1.83%
|
0.61%
|
Assets
1 |
64.16
|
85.57
|
69.21
|
275.1
|
386
|
1,261
|
Book Value Per Share
2 |
14.60
|
12.90
|
7.710
|
32.70
|
34.40
|
35.40
|
Cash Flow per Share
2 |
2.100
|
0.3000
|
0.0600
|
10.60
|
0.2600
|
0.7400
|
Capex
|
-
|
2.02
|
2.33
|
-
|
1.55
|
2.25
|
Capex / Sales
|
-
|
4.7%
|
2.23%
|
-
|
0.61%
|
1.23%
|
Announcement Date
|
12/08/18
|
05/09/19
|
08/09/20
|
02/06/22
|
02/06/22
|
30/08/23
|
|
1st Jan change
|
Capi.
|
---|
| -26.16% | 8.3M | | +0.51% | 76.12B | | -2.92% | 46.57B | | +4.64% | 33.71B | | +12.78% | 18.26B | | +8.85% | 11.59B | | -1.50% | 10.53B | | -22.54% | 10.2B | | -0.53% | 9.21B | | -11.63% | 8.09B |
Diversified Chemicals
|